A Case Study for Critical Reagent Qualification for Ligand Binding Assays Using Equivalence Test Methodology.

Area of Science:

• Biopharmaceutical analysis
• Assay development and validation
• Statistical quality control

Background:

• Regulatory agencies recommend parallel testing of critical reagent lots for ligand binding assays.
• Limited guidance exists on the experimental design for reagent qualification.

Purpose of the Study:

• To present a statistically sound approach for critical reagent qualification using equivalence testing.
• To provide power analysis for designing reagent qualification experiments.

Main Methods:

• Power analysis for equivalence regions (1.25- to 1.5-fold GM ratio).
• Simulation analysis for qualification experiments (6, 12, or 18 plates/lot).
• Evaluation of assay variability (5% to 30% CV).

Main Results:

• A 1.25-fold equivalence region requires 6-12 plates for assays with up to 15% CV.
• Wider equivalence regions are suitable for more variable assays if drift is controlled.
• 12 plates/lot with 1.5σ bounds provide 90% power, aligning with biosimilar attribute testing.

Conclusions:

• Equivalence testing is a statistically valid method for critical reagent qualification.
• Experimental design should consider assay variability and desired equivalence region.
• The proposed method supports robust qualification of critical reagents in ligand binding assays.